LIGAND PHARMACEUTICALS INCORPORATED Public Float
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Public Float of $1.60 billion as of 2025-06-30, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-27
- 2025-06-30: Entity Public Float $1.60B.
- 2024-06-28: Entity Public Float $1.10B.
- 2023-06-30: Entity Public Float $900.00M.
- 2022-06-30: Entity Public Float $1.00B.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $1.60B 10-K · filed 2026-02-27 | |
| 2024-06-28 | $1.10B 10-K · filed 2025-02-28 | |
| 2023-06-30 | $900.00M 10-K · filed 2024-02-29 | |
| 2022-06-30 | $1.00B 10-K · filed 2023-02-28 | |
| 2021-06-30 | $1.80B 10-K · filed 2022-02-28 | |
| 2020-06-30 | $1.20B 10-K · filed 2021-02-24 | |
| 2019-06-28 | $1.80B 10-K · filed 2020-02-27 | |
| 2018-06-30 | $3.60B 10-K · filed 2019-02-28 | |
| 2017-06-30 | $2.20B 10-K · filed 2018-03-01 | |
| 2016-06-30 | $2.30B 10-K · filed 2017-02-28 | |
| 2015-06-30 | $2.30B 10-K · filed 2016-11-14 | $1.90B 10-K · filed 2016-02-26 |
| 2014-06-30 | $1.00B 10-K · filed 2015-02-23 | |
| 2013-06-30 | $676.80M 10-K/A · filed 2014-12-12 | |
| 2012-06-30 | $295.90M 10-K · filed 2013-03-14 | |
| 2011-06-30 | $206.60M 10-K/A · filed 2012-11-14 |